tetano
Editor, Senior Moderator
BMJ Case Rep
. 2020 Jul 7;13(7):e236815.
doi: 10.1136/bcr-2020-236815.
Acute Immune Thrombocytopaenic Purpura in a Patient With COVID-19 and Decompensated Cirrhosis
Florent Artru[SUP] 1 [/SUP], Lorenzo Alberio[SUP] 2 [/SUP], Darius Moradpour[SUP] 1 [/SUP], Gr?goire Stalder[SUP] 3 [/SUP]
Affiliations
Abstract
We report on a patient with coronavirus disease 2019 (COVID-19) and decompensated cirrhosis who experienced a favourable outcome of severe immune thrombocytopaenic purpura (ITP) after administration of intravenous immunoglobulin and high-dose dexamethasone. The present case suggests that it is reasonable to evoke ITP in case of profound thrombocytopaenia in a patient with COVID-19.
Keywords: haematology (incl blood transfusion); infectious diseases.
. 2020 Jul 7;13(7):e236815.
doi: 10.1136/bcr-2020-236815.
Acute Immune Thrombocytopaenic Purpura in a Patient With COVID-19 and Decompensated Cirrhosis
Florent Artru[SUP] 1 [/SUP], Lorenzo Alberio[SUP] 2 [/SUP], Darius Moradpour[SUP] 1 [/SUP], Gr?goire Stalder[SUP] 3 [/SUP]
Affiliations
- PMID: 32641442
- DOI: 10.1136/bcr-2020-236815
Abstract
We report on a patient with coronavirus disease 2019 (COVID-19) and decompensated cirrhosis who experienced a favourable outcome of severe immune thrombocytopaenic purpura (ITP) after administration of intravenous immunoglobulin and high-dose dexamethasone. The present case suggests that it is reasonable to evoke ITP in case of profound thrombocytopaenia in a patient with COVID-19.
Keywords: haematology (incl blood transfusion); infectious diseases.